Clinical Trials Logo

Clinical Trial Summary

The efficiency of T cell based immunotherapies is affected by the insufficient migration and activity of tumor specific effector T cells in the tumor. Aim of this phase I/II clinical trial is to evaluate whether a neoadjuvant, low dose radiotherapy can improve T cell connected anti tumor immune response in colorectal liver metastases.

The primary endpoint is the number of tumor infiltrating T cells. Furthermore the T cell activity in situ, the number of regulatory T cells and the frequency of tumor reactive T cells in the blood and bone marrow will be examined.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01191632
Study type Interventional
Source Heidelberg University
Contact Juergen Weitz, MD
Phone +49 6221 56 6250
Email juergen.weitz@med.uni-heidelberg.de
Status Recruiting
Phase Phase 1/Phase 2
Start date March 2010
Completion date March 2012

See also
  Status Clinical Trial Phase
Completed NCT01255007 - Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver Metastases N/A
Completed NCT00779272 - Impact of Preoperative Chemotherapy on Complications and Regeneration After Resection of Colorectal Liver Metastases N/A
Active, not recruiting NCT00797251 - Anatomical Right Posterior Sectionectomy of the Liver by IOUS-Guided Finger Compression N/A
Recruiting NCT06045286 - High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for MSS CRLM Phase 1
Recruiting NCT04870879 - Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors N/A
Completed NCT01799044 - Pilot-study: Non-thermal Ablation Using Irreversible Electroporation to Treat Colorectal Liver Metastases Phase 1
Terminated NCT00508872 - Folfox-B Study for Patients With Colorectal Liver Metastases Phase 2
Recruiting NCT05877001 - The Safety and Efficacy of HAIC+Tislelizumab+Regorafenib in Patients With Colorectal Liver Metastases Phase 2
Completed NCT02082782 - Efficacy of Irreversible Electroporation (IRE) for Central Colorectal Liver Metastases Phase 2
Completed NCT00942292 - The Effect of Fish Oils on Human Hepatic Colorectal Metastases Phase 2
Completed NCT00119899 - Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases Phase 3
Completed NCT00184834 - Quality of Life and Liver Metastases N/A
Completed NCT00557557 - Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases Phase 1
Recruiting NCT05468593 - Patient Outcomes After Hepatic Artery Infusion Pump Placement
Completed NCT02615665 - Intratumoral CD3+ and NKp46+ Cells in Colorectal Liver Metastases N/A
Terminated NCT01318447 - CyberKnife® for Hepatic Metastases From Colorectal Cancer Phase 2
Completed NCT00885950 - Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants N/A
Completed NCT02331641 - Multiple Minor Hepatectomies Versus Major or Extended Hepatectomies for Colorectal Liver Metastases. N/A
Completed NCT00600522 - Alternative Surgical Policy for Central Liver Tumors N/A
Recruiting NCT05265169 - Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM) N/A